{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:27:20Z","timestamp":1787016440087,"version":"build-2736575974"},"reference-count":24,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Vical Incorporated"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>\n                    VL-2397 is an antifungal drug with a novel mechanism of action, rapid fungicidal\n                    <jats:italic>in vitro<\/jats:italic>\n                    activity, and potent\n                    <jats:italic>in vivo<\/jats:italic>\n                    activity against\n                    <jats:named-content content-type=\"genus-species\">Aspergillus fumigatus<\/jats:named-content>\n                    , including azole-resistant strains. VL2397-101, a phase 1 first-in-human, randomized, double-blind, placebo-controlled dose-escalation study, was conducted in healthy adults to determine the safety, tolerability, and pharmacokinetics (PK) of single and multiple ascending intravenous (i.v.) doses of VL-2397.\n                  <\/jats:p>","DOI":"10.1128\/aac.00969-19","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T05:32:17Z","timestamp":1566192737000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults"],"prefix":"10.1128","volume":"63","author":[{"given":"Mammen P.","family":"Mammen","sequence":"first","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Armas","sequence":"additional","affiliation":[{"name":"Celerion, Tempe, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy L.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Resch","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Rusalov","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Vical Incorporated, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/B978-0-443-06839-3.00258-7","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"Patterson TF","year":"2010","unstructured":"Patterson TF. 2010. Aspergillus species, p 3241\u20133255. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, 7th ed, vol 2. Churchill Livingstone Elsevier Press, Philadelphia, PA.","edition":"7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2508"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/514341"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.46"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.107"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.106"},{"key":"e_1_3_2_9_2","unstructured":"Nakamura I Ohsumi K Yoshikawa K Kanasaki R Masaki T Takase S Hashimoto M Fujie A Nakai T Matsumoto S Takeda S Akamatsu S Uchida S Maki K. 2014. ASP2397: a novel natural product with potent fungicidal activity against Aspergillus spp\u2014a new mode of action and in vitro activity abstr F-1590. Abstr Intersci Conf Antimicrob Agents Chemother."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2012.00028","article-title":"Iron\u2014a key nexus in the virulence of Aspergillus fumigatus","volume":"3","author":"Haas H","year":"2012","unstructured":"Haas H. 2012. Iron\u2014a key nexus in the virulence of Aspergillus fumigatus. Front Microbiol 3:1\u201310.","journal-title":"Front Microbiol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1039\/c4np00071d"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041242"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00239-004-0218-1"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00807-19"},{"key":"e_1_3_2_15_2","unstructured":"Nakamura I Nakai T Matsumoto S Takeda S Akamatsu S Uchida S Koide Y Mitori H Noto T Maki K. 2014. ASP2397: a novel product with potent fungicidal activity against Aspergillus species\u2014in vivo activity against A. fumigatus abstr F-1591. Abstr Intersci Conf Antimicrob Agents Chemother."},{"key":"e_1_3_2_16_2","unstructured":"Nakamura I Ochbuchi M Akabane T Akamatsu S Matsumoto S Takeda S Smith L Sullivan S. 2015. Pharmacokinetic and pharmacodynamics characterization of ASP2397 a novel potent antifungal agent with activity against invasive pulmonary aspergillosis abstr F-746. Abstr Intersci Conf Antimicrob Agents Chemother."},{"key":"e_1_3_2_17_2","unstructured":"Nakamura I Ohbuchi M Matsumoto S Smith L Sullivan S. 2017. Characterization of potential drug interactions and off-target activities of VL-2397 a novel antifungal agent against invasive aspergillosis abstr 235. Abstr ASM Microbe."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Rubino CM Smith LR Mammen M Hopkins AM Lakota EA Sullivan SM. 2017. Pharmacokinetics-pharmacodynamic target attainment analysis to support VL-2397 dose selection for a phase 2 trial in patients with invasive aspergillosis abstr 1515. Abstr IDWeek.","DOI":"10.1093\/ofid\/ofx163.1211"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-19"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw444"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ885"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix210"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.140717"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap7999"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.10.012"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00969-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00969-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:22:53Z","timestamp":1645460573000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00969-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1128\/AAC.00969-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.00969-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00969-19"}}